Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 28 Feb 2023 for PFIZER INC, €438k. Read the official filing
Filing timeline
BuySaleAngela Hwang
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Angela Hwang: trading record in brief
Angela Hwang is a declared insider of Pfizer Inc (chief executive), with filings sourced from SEC (Form 4). The record holds 5 filings, for trades running from 12 November 2021 to 25 February 2023.
Every open-market trade on record is a sale: 1 sale worth €35k. Other entries cover 4 option exercises.
The latest filing, published on 28 February 2023, reports an option exercise of €438k in Pfizer Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Angela Hwang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
20,273 shares@ US$22.8914.9% of flowCommon StockSEC:0001225208-23-002984:0
57,032 shares@ US$30.1755.2% of flowCommon StockSEC:0001225208-23-002832:0
12,716 shares@ US$25.6010.1% of flowCommon StockSEC:0001225208-22-003664:0
21,359 shares@ US$27.3417.8% of flowCommon StockSEC:0001225208-22-003467:0
800 shares@ US$49.611.2% of flowCommon StockSEC:0001225208-21-013881:0
5 of 5 declarations
